A detailed history of Greenleaf Trust transactions in Bio Techne Corp stock. As of the latest transaction made, Greenleaf Trust holds 2,907 shares of TECH stock, worth $207,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,907
Holding current value
$207,210
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$70.96 - $82.35 $206,280 - $239,391
2,907 New
2,907 $232,000
Q1 2024

Apr 29, 2024

BUY
$65.98 - $77.09 $3,562 - $4,162
54 Added 1.8%
3,050 $214,000
Q4 2023

Jan 31, 2024

SELL
$52.83 - $78.22 $2,113 - $3,128
-40 Reduced 1.32%
2,996 $231,000
Q3 2023

Nov 09, 2023

SELL
$67.52 - $89.42 $52,395 - $69,389
-776 Reduced 20.36%
3,036 $206,000
Q2 2023

Aug 09, 2023

BUY
$73.76 - $85.98 $3,688 - $4,299
50 Added 1.33%
3,812 $311,000
Q1 2023

May 11, 2023

BUY
$71.62 - $86.62 $29,793 - $36,033
416 Added 12.43%
3,762 $279,000
Q4 2022

Jan 25, 2023

BUY
$80.67 - $352.29 $207,402 - $905,737
2,571 Added 331.74%
3,346 $277,000
Q3 2022

Nov 10, 2022

BUY
$282.54 - $391.85 $6,498 - $9,012
23 Added 3.06%
775 $220,000
Q2 2022

Aug 12, 2022

SELL
$322.67 - $449.65 $37,429 - $52,159
-116 Reduced 13.36%
752 $261,000
Q1 2022

Apr 27, 2022

BUY
$353.85 - $487.79 $31,138 - $42,925
88 Added 11.28%
868 $376,000
Q4 2021

Feb 11, 2022

BUY
$456.15 - $525.06 $28,281 - $32,553
62 Added 8.64%
780 $404,000
Q3 2021

Nov 12, 2021

SELL
$444.87 - $538.88 $3,114 - $3,772
-7 Reduced 0.97%
718 $348,000
Q2 2021

Aug 10, 2021

BUY
$387.35 - $450.26 $13,169 - $15,308
34 Added 4.92%
725 $326,000
Q1 2021

Apr 30, 2021

BUY
$314.62 - $411.0 $8,809 - $11,508
28 Added 4.22%
691 $264,000
Q4 2020

Feb 08, 2021

BUY
$246.9 - $321.87 $163,694 - $213,399
663 New
663 $211,000
Q2 2018

Aug 07, 2018

SELL
$144.9 - $165.58 $48,831 - $55,800
-337 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$113.59 - $123.78 $38,279 - $41,713
337
337 $41,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.